Clinical Trials Browser

NIH × Leukemia, Myeloid, Acute × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00077181 2013-01-24

3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies

Phase 1 Completed

48 enrolled

LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

3-AP and Cytarabine in Treating Patients With Hematologic Cancer

3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies